Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in mHealthIntelligence referenced a study published in the November 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Therapists’ Perspectives on Access to Melemental Health Among Medicaid-Enrolled Youth,” gathered the perspectives of therapists on the barriers to telemental health in youth who are covered by Medicaid and served in a large safety-net organization.
A study to be published in the April 2024 issue of AJMC, titled “Digital Musculoskeletal Program Is Associated With Decreased Joint Replacement Rates,” was referenced in an article published by Orthopedics. The study found that lower rates of knee and hip arthroplasty at 12 months was lower in adults with osteoarthritis who participated in a digital musculoskeletal program.
An article from The Citizen referenced an article published on AJMC.com, the website of AJMC. The article, “US Has Highest Infant, Maternal Mortality Rates Despite the Most Health Care Spending,” covered a report that found that the United States had the highest infant and maternal mortality rates compared with other high-income countries.
An article from Caribbean Life referenced an article published on AJMC.com. The article, “Diabetes Prevalence Expected to Double Globally by 2050,” covered research that found that the number of patients with diabetes is expected to double from 529 million people in 2021 to at least 1.3 billion in 2050.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
On the Path to Greater Precision in Treating Multiple Myeloma
August 18th 2025Past efforts to collect data and to understand the relationship between minimal residual disease and outcomes will allow help researchers in multiple myeloma develop a new generation of targeted therapies, decide when treatment can be stopped, and possibly screen populations for the disease.
Read More